A groundbreaking trial in the United Kingdom with Eisai and Biogen partnered drug lecanemab has produced ground-breaking results in slowing dementia in the early stages of Alzeimer's disease.
from Health | body+soul https://ift.tt/LcRluNC
Health, Fitness,Dite plan, health tips,athletic club,crunch fitness,fitness studio,lose weight,fitness world,mens health,aerobic,personal trainer,lifetime fitness,nutrition,workout,fitness first,weight loss,how to lose weight,exercise,24 hour fitness,
Labels
Technology
New Post
[recent][newsticker]
MKRdezign
Powered by Blogger.
Post a Comment